GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $980,251 | +30.3% | 510,431 | -2.3% | 0.00% | – |
| Q2 2023 | $752,091 | -31.3% | 522,286 | +0.1% | 0.00% | – |
| Q1 2023 | $1,095,523 | +188783.3% | 521,678 | +1.5% | 0.00% | – |
| Q4 2022 | $580 | -99.9% | 513,815 | -0.0% | 0.00% | – |
| Q3 2022 | $837,000 | +25.1% | 513,902 | +0.5% | 0.00% | – |
| Q2 2022 | $669,000 | -25.5% | 511,139 | -8.4% | 0.00% | – |
| Q1 2022 | $898,000 | -22.5% | 558,240 | -0.3% | 0.00% | – |
| Q4 2021 | $1,158,000 | -44.8% | 559,728 | +3.5% | 0.00% | – |
| Q3 2021 | $2,098,000 | +60.4% | 540,866 | +32.2% | 0.00% | – |
| Q2 2021 | $1,308,000 | -6.6% | 409,013 | -36.7% | 0.00% | – |
| Q1 2021 | $1,401,000 | -2.6% | 645,867 | +0.6% | 0.00% | – |
| Q4 2020 | $1,438,000 | -9.4% | 642,104 | +8.0% | 0.00% | – |
| Q3 2020 | $1,587,000 | -12.6% | 594,621 | +0.2% | 0.00% | – |
| Q2 2020 | $1,816,000 | +65.1% | 593,700 | +5.8% | 0.00% | – |
| Q1 2020 | $1,100,000 | -64.7% | 561,368 | -48.5% | 0.00% | – |
| Q4 2019 | $3,114,000 | +80.4% | 1,089,146 | +131.5% | 0.00% | – |
| Q3 2019 | $1,726,000 | -11.3% | 470,556 | +0.3% | 0.00% | – |
| Q2 2019 | $1,946,000 | +36.2% | 469,063 | +67.7% | 0.00% | – |
| Q1 2019 | $1,429,000 | -8.3% | 279,748 | -38.4% | 0.00% | – |
| Q4 2018 | $1,558,000 | +22.5% | 454,350 | +114.6% | 0.00% | – |
| Q3 2018 | $1,272,000 | -1.2% | 211,765 | +4.5% | 0.00% | – |
| Q2 2018 | $1,288,000 | +39.1% | 202,563 | +3.7% | 0.00% | – |
| Q1 2018 | $926,000 | +42.0% | 195,411 | 0.0% | 0.00% | – |
| Q4 2017 | $652,000 | +57.5% | 195,411 | 0.0% | 0.00% | – |
| Q3 2017 | $414,000 | -13.8% | 195,411 | 0.0% | 0.00% | – |
| Q2 2017 | $480,000 | +92.0% | 195,411 | +79.3% | 0.00% | – |
| Q1 2017 | $250,000 | +135.8% | 109,011 | +0.7% | 0.00% | – |
| Q4 2016 | $106,000 | -12.4% | 108,237 | +0.5% | 0.00% | – |
| Q3 2016 | $121,000 | -23.4% | 107,721 | +0.1% | 0.00% | – |
| Q2 2016 | $158,000 | +3.3% | 107,592 | 0.0% | 0.00% | – |
| Q1 2016 | $153,000 | -13.1% | 107,592 | -0.1% | 0.00% | – |
| Q4 2015 | $176,000 | -24.8% | 107,721 | +7.6% | 0.00% | – |
| Q3 2015 | $234,000 | -14.0% | 100,109 | +0.3% | 0.00% | – |
| Q2 2015 | $272,000 | -29.0% | 99,851 | -12.9% | 0.00% | – |
| Q1 2015 | $383,000 | +0.3% | 114,599 | +4.0% | 0.00% | – |
| Q4 2014 | $382,000 | -30.9% | 110,207 | +0.1% | 0.00% | – |
| Q3 2014 | $553,000 | -63.6% | 110,045 | +0.1% | 0.00% | -100.0% |
| Q2 2014 | $1,518,000 | +33.9% | 109,937 | +48.4% | 0.00% | 0.0% |
| Q1 2014 | $1,134,000 | +92.9% | 74,072 | +1.7% | 0.00% | – |
| Q4 2013 | $588,000 | +32.7% | 72,869 | +64.2% | 0.00% | – |
| Q3 2013 | $443,000 | +214.2% | 44,385 | +34.0% | 0.00% | – |
| Q2 2013 | $141,000 | – | 33,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |